Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer rece...
Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy
About this item
Full title
Author / Creator
Publisher
San Francisco: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
San Francisco: Public Library of Science
Subjects
More information
Scope and Contents
Contents
The spleen is a lymphoid organ and we hypothesize that clinical benefit to immunotherapy may present with an increase in splenic volume during treatment. The purpose of this study was to investigate whether changes in splenic volume could be observed in those showing clinical benefit versus those not showing clinical benefit to pembrolizumab treatm...
Alternative Titles
Full title
Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2686270150
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2686270150
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0270950
